| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 08/10/2006 | US20060177422 co-expressing bicistronically caspase 4 with the human precursor IL-18 polypeptide and purifying the active polypeptide |
| 08/10/2006 | US20060177421 Treatment of allergic conditions by use of il 21 |
| 08/10/2006 | US20060174816 Crystal structure of an angiotensin-converting enzyme (ace) and uses thereof |
| 08/10/2006 | DE102005005542A1 Preparing interleukin-2 (IL-2) for pharmaceutical use, by adding sodium dodecyl sulfate to composition comprising IL-2, removing precipitated covalently-linked IL-2 multimers, and reducing sodium dodecyl sulfate concentration |
| 08/10/2006 | CA2830588A1 Conjugation of streptococcal capsular saccharides |
| 08/10/2006 | CA2597171A1 Antibodies to oncostatin m receptor |
| 08/10/2006 | CA2596953A1 Mhc oligomer and method of making the same |
| 08/10/2006 | CA2596929A1 T cd4+ epitopes of type i and ii latency antigens of the epstein-barr virus, which can be recognised by the majority of individuals in the caucasian population and applications thereof |
| 08/10/2006 | CA2596913A1 Salt taste receptor and its use in an assay for salt taste |
| 08/10/2006 | CA2596852A1 Method for evaluating quality of beef such as taste and texture through genotyping |
| 08/10/2006 | CA2596833A1 Human antibodies and proteins |
| 08/10/2006 | CA2596715A1 Screening method |
| 08/10/2006 | CA2596698A1 Papillomavirus l2 n-terminal peptides for the induction of broadly cross-neutralizing antibodies |
| 08/10/2006 | CA2596697A1 Human antibodies against rabies and uses thereof |
| 08/10/2006 | CA2596674A1 Novel peptides which interact with anti-apoptotic members of the family of bcl-2 proteins and use thereof |
| 08/10/2006 | CA2596672A1 Motif of beclin protein which interacts with anti-apoptotic members of the family of bcl-2 proteins and use thereof |
| 08/10/2006 | CA2596661A1 Novel hydrophobin fusion products, production and use thereof |
| 08/10/2006 | CA2596514A1 Riproximin , a novel type ii ribosome-inactivating protein and uses thereof |
| 08/10/2006 | CA2596280A1 Compositions and methods for less immunogenic protein formulations |
| 08/10/2006 | CA2595904A1 Blys fusion proteins for targeting blys receptor and methods for treatment of b-cell proliferative disorders |
| 08/10/2006 | CA2595901A1 Axmi-018, axmi-020, and axmi-021, a family of delta-endotoxin genes and methods for their use |
| 08/10/2006 | CA2593714A1 Survivin peptide vaccine |
| 08/10/2006 | CA2564251A1 Variable lymphocyte receptors, related polypeptides and nucleic acids, and uses thereof |
| 08/10/2006 | CA2556226A1 Amylin family peptides and methods for making and using them |
| 08/09/2006 | EP1688498A1 A recombinant protein with cancer suppression action, its encoding gene and use |
| 08/09/2006 | EP1688497A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 08/09/2006 | EP1688496A2 Regulation of human P2Y1-like G protein-coupled receptor |
| 08/09/2006 | EP1688495A1 MU-1 member of the cytokine receptor family |
| 08/09/2006 | EP1688494A1 Monkey npy y4 recepotr and method of evaluating compound |
| 08/09/2006 | EP1688490A1 Dose-dependent promoter originating in humans |
| 08/09/2006 | EP1688487A1 Method of controlling transcription of insulin gene |
| 08/09/2006 | EP1688486A1 Antibacterial peptide and utilization of the same |
| 08/09/2006 | EP1688485A1 Culturing circular ssDNA viruses for the production of vaccines |
| 08/09/2006 | EP1688482A1 Method for producing L-amino acid using bacteria belonging to the genus Escherichia |
| 08/09/2006 | EP1688439A1 Fused protein composition |
| 08/09/2006 | EP1688431A2 Analogs of thymosin alpha 1 |
| 08/09/2006 | EP1688430A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 08/09/2006 | EP1688429A1 Riproximin, a novel type II ribosome-inactivating protein and uses thereof |
| 08/09/2006 | EP1688428A1 Method of antigen incorporation into neisseria bacterial outer membrane vesicles and resulting vaccine formulations |
| 08/09/2006 | EP1687637A1 High-throughput screening method for integrin antagonist and new peptide screened therefrom |
| 08/09/2006 | EP1687636A2 Rapid determination of hepatocyte growth factor (hgf) in the body fluids |
| 08/09/2006 | EP1687435A1 Insect resistance using inhibition of gene expression |
| 08/09/2006 | EP1687431A2 Compositions and methods for screening pro-apoptotic compounds |
| 08/09/2006 | EP1687430A1 Immunization against chlamydia infection |
| 08/09/2006 | EP1687428A1 Processes for making acylated insulin |
| 08/09/2006 | EP1687427A2 Methods for modulating neuronal responses |
| 08/09/2006 | EP1687426A2 Antiangiogenicpeptides for treating or preventing endometriosis |
| 08/09/2006 | EP1687423A2 Dna vaccines encoding hsp60 peptide fragments for treating autoimmune diseases |
| 08/09/2006 | EP1687421A2 A process for producing exogenous protein in the milk of trangenic mammals and a process for purifying proteins therefrom |
| 08/09/2006 | EP1687419A1 Hybrid enzymes |
| 08/09/2006 | EP1687402A2 Chimeric metabotropic glutamate receptors and uses thereof |
| 08/09/2006 | EP1687337A1 A method for the treatment of malignant diseases by inhibiting nucleolin |
| 08/09/2006 | EP1687335A2 Cancer diagnosis and therapy |
| 08/09/2006 | EP1687334A2 Mucin antigen vaccine |
| 08/09/2006 | EP1687333A2 Method for down-regulation of vegf |
| 08/09/2006 | EP1687332A2 Polynucleotides overexpressed in breast cancer cells , compositions and methods for the therapy and diagnosis of breast cancer |
| 08/09/2006 | EP1687331A1 Tyrosine phosphorylation of cdk inhibitor proteins of the cip/kip family |
| 08/09/2006 | EP1687330A1 Peptides with anti-obesity activity and other related uses |
| 08/09/2006 | EP1687329A2 Optimized expression of hpv 58 l1 in yeast |
| 08/09/2006 | EP1687328A1 Process for purifying proteins in a hydrophobic interaction chromatography flow-through fraction |
| 08/09/2006 | EP1687325A2 Novel sequences encoding hapatitis c virus glycoproteins |
| 08/09/2006 | EP1687324A2 Improved expression systems with sec-system secretion |
| 08/09/2006 | EP1687032A1 Therapeutic regimen for treating cancer |
| 08/09/2006 | EP1687022A2 Renta: an hiv immunogen and uses thereof |
| 08/09/2006 | EP1687017A2 Methods and compositions for delivering polynucleotides |
| 08/09/2006 | EP1687016A2 Diphtheria toxin variant |
| 08/09/2006 | EP1572714A4 VMP-LIKE SEQUENCES OF PATHOGENIC i BORRELIA /i SPECIES AND STRAINS |
| 08/09/2006 | EP1562984B1 Sandwich immunoassay for identifying partial proanp peptides |
| 08/09/2006 | EP1553977B1 Vaccine against infections caused by oncoviruses such as the feline leucosis virus of cats |
| 08/09/2006 | EP1551982A4 Transcriptional control element, chimeric constructs and uses therefor |
| 08/09/2006 | EP1549951A4 Semaphorin-like proteins and methods of using same |
| 08/09/2006 | EP1499175A4 Identification and characterization of an anthocyanin mutant (ant1) in tomato |
| 08/09/2006 | EP1354032B1 Gene regulation therapy involving ferritin |
| 08/09/2006 | EP1307481B1 Inhibitory pas domain protein (ipas) and screening methods related to angiogenesis and tumor progression |
| 08/09/2006 | EP1290032B1 Antibodies against particular forms of propsa and use thereof in immunoassays |
| 08/09/2006 | EP1228229B1 Control of post-transcriptional gene silencing in plants |
| 08/09/2006 | EP1200604B1 Production of proteins |
| 08/09/2006 | EP1177317B1 POLYNUCLEOTIDE PROBES FOR exclusive DETECTION AND QUANTITATION OF STAPHYLOCOCCUS |
| 08/09/2006 | EP1171157B1 Use of glucose-6-phospate isomerase and antibodies thereto for the diagnosis and therapy of arthritis, and test of anti-arthritic compounds |
| 08/09/2006 | EP1165750B1 Diagnosis of whipple disease |
| 08/09/2006 | EP1163639A4 Protein modeling tools |
| 08/09/2006 | EP1146900B1 Dna vaccines against hantavirus infections |
| 08/09/2006 | EP1069135B1 Proteins having immunomodulatory activity and remedies for immunological diseases |
| 08/09/2006 | EP1051619B1 Method for identifying t-cell stimulating protein fragments |
| 08/09/2006 | EP1040192B1 Insect-resistant transgenic plants and methods for improving delta-endotoxin activity against insects |
| 08/09/2006 | EP1037650B1 Compositions for the treatment of staphylococcus aureus infections |
| 08/09/2006 | EP1021721B1 Assays for tsh receptor autoantibodies |
| 08/09/2006 | EP1012177B1 Estrogen receptor |
| 08/09/2006 | EP1005487B1 The 74 kilodalton outer membrane protein from moraxella catarrhalis |
| 08/09/2006 | EP0988316B1 Methods and compositions for diagnosis and treatment of iron overload diseases and iron deficiency diseases |
| 08/09/2006 | EP0972075B1 Methods for assessing cardiovascular status and compositions for use thereof |
| 08/09/2006 | EP0951472B1 Peptide compositions with growth factor-like activity |
| 08/09/2006 | EP0939763B1 Directed switch-mediated dna recombination |
| 08/09/2006 | EP0935656B1 Hedgehog interacting proteins and uses related thereto |
| 08/09/2006 | EP0920305B1 Identification of genes altered in multiple myeloma |
| 08/09/2006 | EP0910659B1 Antibodies against a complex of cd4 and a chemokine receptor domain, and their use against hiv infections |
| 08/09/2006 | EP0827513B1 Reagents for treatment and diagnostic visualisation, particularly in cancer |
| 08/09/2006 | EP0808374B1 A farnesoid activated receptor (FAR) and method for screening for modulators of processes mediated by the FAR |
| 08/09/2006 | EP0781342B1 Phytopathogenic dna virus resistant transgenic plants and seeds and methods for obtaining same |
| 08/09/2006 | EP0759988B1 NUCLEIC ACIDS OF $i(ROCHALIMAEA HENSELAE) AND $i(ROCHALIMAEA QUINTANA) AND METHODS AND COMPOSITIONS FOR DIAGNOSING $i(ROCHALIMAEA HENSELAE) AND $i(ROCHALIMAEA QUINTANA) INFECTION |